Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

Ecolab Has 'Earnings Consistency,' Downside Risk Is 'Relatively Benign': Analyst

Published 03/04/2024, 15:42
Updated 03/04/2024, 17:10
© Reuters.  Ecolab Has 'Earnings Consistency,' Downside Risk Is 'Relatively Benign': Analyst

Benzinga - by Priya Nigam, Benzinga Staff Writer.

Shares of Ecolab Inc (NYSE: ECL) were rising in early trading on Wednesday.

The downside risk to the company’s earnings seems “relatively benign,” given its business model and strategy, according to Piper Sandler.

The Ecolab Analyst: Charles Neivert initiated coverage of Ecolab with an Overweight rating and price target of $260.

The Ecolab Thesis: The company’s earnings trajectory has been mostly consistent, in sharp contrast to other companies in the sector, which face “substantial cyclicality,” Neivert said in the initiation note.

Check out other analyst stock ratings.

Efforts to increase sustainability and reduce resource consumption “are taking on increasing importance within the customer base and ECL has a broad range of products and services to offer, which we think allows them to increase their engagement with almost every customer it currently serves,” the analyst stated.

“Our EBITDA estimate is above the 2025 consensus estimate of $3.76B based on our slightly more constructive outlook for key end markets, the increasing value of the products and services ECL brings to its customers, which in turn drive the company’s ability to raise prices in the future, and our belief that ECL should benefit from continuing multiple expansion as it drives its margin toward 20%,” he added.

ECL Price Action: Shares of Ecolab had risen by 0.26% to $228.04 at the time of publication on Wednesday.

Image: Shutterstock

Latest Ratings for ECL

Mar 2022BarclaysMaintainsOverweight
Feb 2022Morgan StanleyMaintainsEqual-Weight
Feb 2022Credit SuisseMaintainsNeutral

View the Latest Analyst Ratings

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.